Mario R. Ehlers
Plus aucun poste en cours
Profil
Mario R.
Ehlers worked as a Biochemistry Instructor at Harvard Medical School from 1987 to 1992.
He then became the Chairman of the Medical Biochemistry Department at the University of Cape Town from 1992 to 1998.
From 1998 to 2002, he served as the Chief Medical Officer & Senior Vice President at Restoragen, Inc. He then worked as the Chief Medical Officer at NorWesTech, Inc. from 2002 to 2008.
From 2009 to 2011, he was the Director at NorWesTech, Inc. He also served as the Deputy Director of the Clinical Trials Group at Immune Tolerance Network.
Dr. Ehlers earned a doctorate degree from the University of Cape Town.
Anciens postes connus de Mario R. Ehlers
| Sociétés | Poste | Fin |
|---|---|---|
NorWesTech, Inc.
 NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | 31/08/2011 |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | 22/08/2008 |
| Restoragen, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2002 |
| University of Cape Town | Corporate Officer/Principal | 01/01/1998 |
| Harvard Medical School | Corporate Officer/Principal | 01/01/1992 |
Formation de Mario R. Ehlers
| University of Cape Town | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | Finance |
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Commercial Services |
| Restoragen, Inc. | Health Technology |
